Jeevan Reddy

Jeevan Reddy currently serves as the Manager of Regulatory Affairs at RiconPharma India Pvt Ltd, where he plays a pivotal role in ensuring the compliance and safety of sterile dosage forms, including parenteral and ophthalmic products. With a focus on New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs), Jeevan is dedicated to regulating a select portfolio of molecules that contribute to the well-being of humanity. His expertise in regulatory affairs is complemented by a robust understanding of Good Manufacturing Practices (GMP), which he applies to uphold the highest standards of sterility assurance in the production process.

In his current role, Jeevan is responsible for navigating the complex landscape of regulatory requirements set forth by the U.S. Food and Drug Administration (FDA) and other global health authorities. His adept negotiation skills and flexible approach enable him to effectively collaborate with cross-functional teams, ensuring that projects remain on track and within budget. Jeevan's commitment to customer service is evident in his proactive communication with stakeholders, ensuring that all regulatory submissions are timely and comprehensive.

Key projects under his leadership have included the successful submission of multiple NDAs and ANDAs, which have significantly expanded RiconPharma's product offerings in the sterile dosage form market. His ability to manage regulatory timelines and budgets while maintaining a focus on quality and compliance has solidified his reputation as a trusted leader in the field. As he continues to drive innovation and regulatory excellence at RiconPharma, Jeevan remains committed to advancing the pharmaceutical industry for the benefit of patients worldwide.